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Abstract
The CRF system of the central nucleus of the amygdala (CeA) is important for the processing of 
anxiety, stress, and effects of acute and chronic ethanol. We previously reported that ethanol 
decreases evoked glutamate transmission in the CeA of Sprague Dawley rats and that ethanol 
dependence alters glutamate release in the CeA. Here, we examined the effects of ethanol, CRF 
and a CRF1 receptor antagonist on spontaneous and evoked glutamatergic transmission in CeA 
neurons from Wistar and Marchigian Sardinian Preferring (msP) rats, a rodent line genetically 
selected for excessive alcohol drinking and characterized by heightened activity of the CRF1 
system. Basal spontaneous and evoked glutamate transmission in CeA neurons from msP rats was 
increased compared to Wistar rats. Ethanol had divergent effects, either increasing or decreasing 
spontaneous glutamate release in the CeA of Wistar rats. This bidirectional effect was retained in 
msP rats, but the magnitude of the ethanol-induced increase in glutamate release was significantly 
smaller. The inhibitory effect of ethanol on evoked glutamatergic transmission was similar in both 
strains. CRF also either increased or decreased spontaneous glutamate release in CeA neurons of 
Wistar rats, however, in msP rats CRF only increased glutamate release. The inhibitory effect of 
CRF on evoked glutamatergic transmission was also lost in neurons from msP rats. A CRF1 
antagonist produced only minor effects on spontaneous glutamate transmission, which were 
consistent across strains, and no effects on evoked glutamate transmission. These results 
demonstrate that the genetically altered CRF system of msP rats results in alterations in 
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spontaneous and stimulated glutamate signaling in the CeA that may contribute to both the anxiety 
and drinking behavioral phenotypes.
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1. Introduction
The central nucleus of the amygdala (CeA) is the brain region responsible for the emotional 
processing of internal and external stimuli that contributes to the behavioral manifestations 
of fear, anxiety, and stress (Koob and Le Moal, 2008). As a major component of the 
“extended amygdala,” the CeA has also been shown to be a major neural substrate for the 
motivational effects of alcohol and drugs of abuse (Alheid and Heimer, 1988). Primarily 
composed of GABAergic neurons (Pitkanen and Amaral, 1994; Veinante and Freund-
Mercier, 1998), the CeA receives excitatory input from glutamatergic afferent projections 
from the basolateral amygdala, cortex, thalamus, and brainstem (Pitkanen et al., 2000; 
Veinante and Freund-Mercier, 1998).
The brain stress peptide corticotropin-releasing factor (CRF) and its G protein-coupled 
receptors CRF1 and CRF2 are expressed throughout the CeA and exert neuromodulatory 
effects on excitatory and inhibitory synaptic transmission via intracellular pathways 
promoting facilitation or depression of neurotransmitter release (Gallagher et al., 2008). 
CRF plays crucial roles in integrating the body’s overall response to stress (Koob et al., 
1999) and is critical in behavioral aspects of addiction, including the anxiogenic effects of 
drug withdrawal (Breese et al., 2005; Heinrichs et al., 1995; Menzaghi et al., 1994). The 
CRF system is also heavily implicated in negative reinforcement, particularly within the 
extended amygdala (Koob, 2008; Sinha, 2008). Blockade of CRF in the extended amygdala 
selectively reduces dependence-induced drinking in rodents (Koob, 2008; Zorrilla et al., 
2013). Ethanol dependence has been shown to result in upregulation of the CRF stress 
system in the CeA (Roberto et al., 2010). Notably, chronic treatment with a systemic CRF1 
antagonist blocked development of withdrawal-induced increases in alcohol drinking by 
dependent rats, and also tempered the moderate increases in alcohol consumption by non-
dependent rats over the course of intermittent testing (Roberto et al., 2010).
The actions of CRF in the development of alcohol dependence have recently been expanded 
to include a role in genetic susceptibility. Gene association studies in humans suggest that 
the Crhr1 locus mediates an inherent genetic vulnerability to drinking (Treutlein et al., 
2006). It has been theorized that the heightened sensitivity to stress conferred by genetic 
variation in the CRF1 receptor could also confer a predisposition to develop alcohol 
dependence, particularly when occurring in conjunction with environmental factors related 
to stress (Enoch and Goldman, 1999; Pohorecky, 1991; Treutlein et al., 2006). The 
Marchigian Sardinian Preferring (msP) rat strain is characterized by upregulated CRF1 
mRNA in several limbic brain areas, that is linked to two single nucleotide polymorphisms 
occurring in the promoter region (position −1836 and −2097) of the gene encoding for the 
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CRF1 receptor (Hansson et al., 2007). The msP rats exhibit an excessive daily ethanol 
drinking that occurs in binge-like bouts of consumption resulting in blood alcohol levels as 
high as 100-120 mg/dl (Ciccocioppo et al., 2006). The msP rats display an increased stress 
response, as well as an increased vulnerability to stress-induced reinstatement (Ayanwuyi et 
al., 2013; Ciccocioppo et al., 2006; Ciccocioppo et al., 1999b; Cippitelli et al., 2015). There 
are similarities in drinking behavior of msP rats and control rats that have been made 
dependent on ethanol, most notably, that the increased ethanol consumption in msP and 
dependent rats can be reversed by administration of CRF1 antagonists (Gehlert et al., 2007; 
Hansson et al., 2006). Chronic voluntary drinking has been shown to reverse amygdala 
CRF1 receptor overexpression and attenuate negative affect in msP rats (Ciccocioppo et al., 
1999a; Hansson et al., 2007). Previous studies have implicated changes in the CeA in the 
ethanol sensitive phenotype of the msP rats (Economidou et al., 2008; Hansson et al., 2007; 
Hansson et al., 2006). We previously reported changes in the GABA system in the medial 
CeA of msP rats (Herman et al., 2013) that mimic the changes observed in ethanol 
dependence (Roberto et al., 2003; Roberto et al., 2004a), but to our knowledge no studies 
have examined alterations in the glutamatergic system in the msP rats.
Glutamate is the major excitatory neurotransmitter and its modulation by ethanol contributes 
to ethanol reinforcement, tolerance and dependence (Lovinger and Roberto, 2013). We have 
previously reported that ethanol decreases evoked glutamatergic transmission in the CeA 
and that baseline spontaneous glutamatergic transmission is elevated in rats following 
chronic ethanol treatment (Roberto et al., 2004b), but we did not examine the role of the 
CRF system in the effects of ethanol on glutamatergic transmission. Previous work shows 
that CRF increases glutamate release in the CeA and that this effect is increased in fear-
conditioned animals (Skorzewska et al., 2009), and altered with cocaine chronic exposure 
(Liu et al., 2005; Pollandt et al., 2006). CRF also increases the frequency of spontaneous 
glutamate currents in neurons in the lateral CeA (Silberman and Winder, 2013). Notably, 
CRF and the CRF-like peptide urocortin I produce opposing effects on glutamatergic 
transmission in the CeA by presynaptic CRF1 and pre- and postsynaptic CRF2 mechanisms, 
respectively (Gallagher et al., 2008; Liu et al., 2004; Orozco-Cabal et al., 2006), 
underscoring the complexity of the CRF system in the regulation of excitatory transmission.
In the present study we used an in vitro slice preparation to assess the specific 
electrophysiological differences in spontaneous and evoked glutamatergic transmission in 
the medial CeA of msP rats compared to Wistar rats, and how ethanol and stimulation or 
blockade of the CRF system affect glutamatergic transmission in the medial CeA.
2. Methods
2.1. Animals
In the present study we used 51 adult male (254.3 ± 8.8 g) msP rats maintained at The 
Scripps Research Institute and obtained from the School of Pharmacy at the University of 
Camerino (Italy). For the strain comparison, we used 46 adult male (250.9 ± 8.0 g) Wistar 
rats obtained from Charles River (Raleigh, NC) as this is the strain from which msP rats 
were originally selected. To control for inter-animal variability, cells were collected from a 
minimum of 3 rats for each experimental condition. All rats were housed in a temperature- 
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and humidity-controlled room on a 12-h light/dark cycle (lights on at 6:00 am) with food 
and water available ad libitum. We conducted all care, msP colony breeding and surgical 
procedures in accordance with the National Institutes of Health Guide for the Care and Use 
of Laboratory Animals and with the Institutional Animal Care and Use Committee (IACUC) 
policies of The Scripps Research Institute.
Electrophysiological studies
2.2 Slice preparation
We prepared CeA slices as previously described (Herman et al., 2013) from Wistar rats and 
genetically-selected Marchigian Sardinian (msP) rats that were anesthetized with isoflurane 
(3-5%) and rapidly decapitated. We cut coronal slices 300-400 μm thick on a Leica 1000S 
vibratome (Campden, Lafayette, Indiana), incubated them in an interface configuration for 
30-60 min, and then completely submerged and continuously superfused (flow rate of 2-4 
ml/min) and equilibrated them with 95% O2/5% CO2 artificial cerebrospinal fluid (aCSF) of 
the following composition (in mM): NaCl, 130; KCl, 3.5; NaH2PO4, 1.25; MgSO4•7H2O, 
1.5; CaCl2, 2.0; NaHCO3, 24; glucose, 10. Drugs were added to the aCSF from stock 
solutions to obtain known concentrations in the superfusate.
2.3. Whole-cell patch-clamp recording of glutamate currents
We recorded from 204 neurons in the medial CeA (88 cells from msP rats, 116 cells from 
Wistar rats) visualized in brain slices (300 μm) using infrared differential interference 
contrast (IR-DIC) optics and CCD cameras (EXi Aqua and ROLERA-XR, QImaging) 
(Herman et al., 2013). A w60 or w40 water immersion objective (Olympus) was used for 
identifying and approaching CeA neurons. Whole-cell voltage-clamp recordings were made 
with a Multiclamp 700B amplifier (Molecular Devices), low-pass filtered at 2-5 kHz, 
digitized (Digidata 1440A; Molecular Devices), and stored on a PC using pClamp 10 
software (Axon Instruments). All voltage-clamp recordings were performed in a gap-free 
acquisition mode with a sampling rate per signal of 10 kHz. Patch pipettes (3-6 MΩ) were 
pulled from borosilicate glass (Warner Instruments and King Precision) and filled with an 
internal solution composed of (in mM): 145 Kgluconate; 0.5 EGTA; 2 MgCl2; 10 HEPES; 2 
Na-ATP; 0.2 Na-GTP. Spontaneous excitatory postsynaptic currents (sEPSCs) were 
recorded in the presence of 30 μM bicuclline and 1 μM [1-(S)-3,4-
dichlorophenyl)ethyl]amino-2-(S)-hydroxypropyl-p-benzylphosphonic acid (CGP 55845A). 
Miniature EPSCs (mEPSCs) were recorded under identical conditions with the addition of 1 
μM tetrodotoxin (TTX). Drugs were constituted in aCSF and applied by bath superfusion. 
All cells were clamped at −60 mV for the duration of the recording. In all experiments, 
series resistance (<15 MΩ) was continuously monitored with a 10 mV hyperpolarizing pulse 
and experiments with >20% change in series resistance were not included in the final 
analysis.
2.4. Intracellular recording of evoked responses
We recorded from 84 CeA neurons (from the medial subdivision of the CeA) with sharp 
micropipettes filled with 3M KCl using discontinuous current-clamp mode (Cruz et al., 
2012; Haubensak et al., 2010; Kallupi et al., 2014; Roberto et al., 2004a). We held most 
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neurons near their resting membrane potential (RMP). Data were acquired with an 
Axoclamp-2A preamplifier and stored for later analysis using pClamp software (Axon 
Instruments, Foster City, CA). We evoked pharmacologically isolated compound excitatory 
postsynaptic potentials (EPSPs) by stimulating locally within the CeA through a bipolar 
stimulating electrode and superfusing the slices with the GABA receptor blockers: 30 μM 
bicuculline (to block GABAA receptors) and 1 μM CGP 55845A (to block GABAB 
receptors) in the aCSF. At the end of the recording we often superfused 30 μM DNQX and 
30 μM DL-AP-5 to confirm the glutamatergic nature of the EPSP. To determine the synaptic 
response parameters for each cell, we performed an input-output protocol (Kallupi et al., 
2014; Roberto et al., 2003; Roberto et al., 2004a) consisting of a range of five current 
stimulations (50-250 mA; 0.125 Hz), starting at the threshold current required to elicit an 
EPSP up to the strength required to elicit the maximum amplitude. These stimulus strengths 
were maintained throughout the entire duration of the experiment.
2.5. Drugs
We purchased CGP 55845A, picrotoxin and bicuculline from Sigma (St. Louis, MO), 
tetrodotoxin from Biotum (Hayward, CA); and ethanol from Remet (La Mirada, CA). r/
hCRF was synthesized by Dr. Jean Rivier at the Salk Institute for Biological Studies. 
R121919 was synthesized by Dr. Kenner Rice at the Drug Design and Synthesis Section, 
Chemical Biology Research Branch, National Institute on Drug Abuse, National Institutes of 
Health, Bethesda, MD.
2.6. Data analysis and statistics
Frequency, amplitude and kinetics of EPSCs were analyzed and visually confirmed using a 
semi-automated threshold-based mini detection software (Mini Analysis, Synaptosoft Inc., 
Fort Lee, NJ). Averages of EPSC characteristics were based on a minimum time interval of 
3-5 min and a minimum of 60 events. All detected events were used for event frequency 
analysis, but superimposed events were eliminated for amplitude and decay kinetic analysis. 
Experimental groups were divided on a cell-by-cell basis using the functional response 
(either a clear increase or decrease (> or < than 100%) over normalized baseline values). All 
data are expressed as mean ± SEM. We quantified the synaptic responses by calculating the 
EPSP amplitude with Clampfit software (Axon Instruments). We examined paired-pulse 
facilitation (PPF) in each neuron using paired stimuli at 50 and 100 msec inter-stimulus 
interval (Kallupi et al., 2014; Roberto et al., 2004a). The stimulus strength was adjusted such 
that the amplitude of the first EPSP was 50% of maximal, determined from the I-O 
relationship. We calculated the PPF ratio as the second EPSP amplitude over that of the first 
EPSP
To analyze data acquired from intracellular and whole cell recordings, we used Clampfit 
10.2 (Molecular Devices) and MiniAnalysis 5.1 software (Synaptosoft, Leonia, NJ), 
respectively. We used GraphPad Prism 5.0 software (GraphPad Software, San Diego, CA) 
for all statistical analysis of results. The EPSC results were analyzed for independent 
significance using a one-sample t-test and compared using a two-tailed t-test for independent 
samples, a paired two-tailed t-test for comparisons made within the same recording, and a 
one-way ANOVA with a Bonferroni post hoc analysis for comparisons made between 3 or 
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more groups. All statistical analysis was performed using Prism 5.02 (GraphPad, San Diego, 
CA). Data are presented as mean ± standard error. In all cases, p<0.05 was the criterion for 
statistical significance.
3. Results
3.1. Baseline spontaneous and evoked CeA glutamatergic transmission is elevated in msP 
rats compared to Wistar rats
We assessed baseline glutamatergic signaling in adult male Wistar and msP rats using 
whole-cell voltage clamp recordings of pharmacologically-isolated spontaneous excitatory 
postsynaptic currents (sEPSCs) in the medial subdivision of the CeA. CeA neurons from 
msP rats had a significantly higher baseline sEPSC frequency (1.3 ± 0.2 Hz; n = 19) 
compared to CeA neurons from Wistar rats (0.6 ± 0.1 Hz; n = 26; Figure 1A and C; p<0.05 
by unpaired t-test). There were no differences between msP and Wistar rats in sEPSC 
amplitude (26.3 ± 1.2 and 25.2 ± 0.8 pA, respectively), rise (1.8 ± 0.1 and 1.8 ± 0.08 ms, 
respectively) or decay time (1.8 ± 0.2 and 1.5 ± 0.1 ms, respectively; p>0.05 by one-way 
ANOVA). Action potential-independent glutamatergic transmission was examined in 
recordings of miniature EPSCs (mEPSCs) using whole-cell voltage clamp recordings in the 
presence of tetrodotoxin (TTX, 1 μM). In contrast to the difference observed in baseline 
sEPSC frequency, there was no difference in baseline mEPSC frequency between CeA 
neurons from msP rats (0.5 ± 0.1 Hz; n = 17) and CeA neurons from Wistar rats (0.6 ± 0.1 
Hz; n = 18; Figure 1B and 1D; p>0.05 by unpaired t-test). In addition there were no 
significant differences between msP and Wistar rats in mEPSC amplitude (26.0 ± 1.8 and 
26.8 ± 1.0 pA, respectively), rise (2.1 ± 0.1 and 1.8 ± 0.1 ms, respectively) or decay time 
(1.9 ± 0.2 and 1.5 ± 0.1 ms, respectively; p>0.05 by one-way ANOVA). Generally, changes 
in the frequency of EPSCs reflect changes in the probability of glutamate release, while 
changes in EPSC amplitude and kinetics reflect change in postsynaptic glutamatergic 
receptor function (De Koninck and Mody, 1994). Collectively, these results indicate that 
msP rats exhibit elevated CeA action potential-dependent, but not vesicular, glutamate 
release compared to Wistar rats.
We also recorded intracellularly, with sharp pipettes, and evoked pharmacologically isolated 
compound glutamatergic EPSPs (eEPSPs) by stimulating locally within the medial CeA. We 
recorded from 84 CeA neurons from either Wistar or msP rats with a mean RMP of −79 ± 
1.0 mV and a mean input resistance of 142 ± 7.5 MΩ. The two groups did not show 
significant differences in these properties, or the voltage–current relationship (not shown). 
Baseline eEPSP input–output curves generated by equivalent stimulus intensities were 
significantly (p<0.05; by unpaired t-test) higher in CeA neurons from msP rats (n = 36) 
compared to those from Wistar rats (n = 28) (Figure 2A), suggesting a strain difference in 
evoked glutamatergic transmission. We examined paired-pulse facilitation (PPF) of the 
eEPSPs at 50 and 100 ms inter-stimulus intervals, a phenomenon whereby a secondary 
synaptic response is influenced by a preceding primary stimulus of equal intensity 
(Andreasen and Hablitz, 1994; Manabe et al., 1993). Generally, changes in the PPF ratio 
(second EPSP/first EPSP) are inversely related to transmitter release such that a reduction of 
the PPF ratio is associated with an increased probability of transmitter release (Andreasen 
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and Hablitz, 1994). We found a significantly (p<0.05 by unpaired t-test) lower (50 msec: 
1.25 ± 0.06; 100 msec, 1.28 ± 0.06; n = 38) basal PPF ratio of EPSPs from neurons of msP 
rats compared to Wistar rats (50 msec: 1.58 ± 0.08; 100 msec, 1.51 ± 0.09; n = 26) (Figure 
2B), suggesting augmented baseline evoked network dependent glutamate release in the msP 
rats. Thus, the elevated eEPSPs, decreased PPF ratio of eEPSPs and the enhanced frequency 
of sEPSCs taken together point to enhanced action-potential dependent glutamate release in 
CeA of msP compared to Wistar..
3.2. The divergent effects of ethanol on spontaneous CeA glutamatergic transmission are 
altered in msP as compared to Wistar rats
To determine if ethanol produced strain-specific effects in CeA neurons from msP and 
Wistar rats, we performed whole-cell recordings of glutamate currents during superfusion of 
ethanol (EtOH, 44 mM; 10-12 min). When averaged together, the effects of ethanol are 
found to be nonsignificant (Figure 3C), however, a close examination of the data suggests 
that ethanol produces divergent effects on glutamate transmission. In a subset of neurons 
(7/17) there was a significant increase in sEPSC frequency (172.7 ± 15.2 % of control; 
*p<0.05 by one-sample t-test), and in the remaining neurons (10/17) there was a significant 
decrease in sEPSC frequency (58.2 ± 6.9 % of control; *p<0.05 by one-sample t-test; 
Figure 3A and 3C), suggesting increased or decreased action potential-dependent glutamate 
release, respectively. In contrast, in 9/17 neurons from msP rats, superfusion of ethanol 
(EtOH, 44 mM) produced an increase in sEPSC frequency that was significantly less than 
that observed in neurons from Wistar rats (109.7 ± 2.6 % of control *p<0.05; #p<0.05 by 
one-way ANOVA Bonferroni post hoc analysis). In the remaining 8/17 neurons a significant 
decrease in sEPSC frequency was still observed (78.2 ± 5.7 % of control; *p<0.05 by one-
sample t-test; Figure 3B and 3C). Ethanol produced no consistent differences in sEPSC 
amplitude, rise time or decay time between CeA neurons from msP and Wistar rats.
The effects of ethanol on mEPSC frequency were similar to those observed with sEPSCs, 
although with a smaller overall magnitude. In Wistar rats, ethanol produced a small but 
significant increase in mEPSC frequency (114.7 ± 3.3 % of control; *p<0.05 by one-sample 
t-test) in 7/18 neurons and a significant decrease (68.7 ± 5.1 % of control; *p<0.05 by one-
sample t-test; Figure 3D) in 11/18 neurons. In msP rats, ethanol produced no significant 
change in mEPSC frequency (112.7 ± 3.7 % of control) in 5/13 neurons and a significant 
decrease (73.9 ± 5.2 % of control; *p<0.05 by one-sample t-test; Figure 3D) in 7/13 
neurons. Ethanol produced no significant differences in mEPSC amplitude, rise time or 
decay time between CeA neurons from msP and Wistar rats.
3.3. The divergent effects of CRF are lost in action potential-dependent glutamatergic 
transmission in the CeA of msP as compared to Wistar rats
We then examined the strain-specific effects of CRF on EPSCs in CeA neurons from msP 
and Wistar rats. Similar to what was observed with ethanol, CRF (100 nM; 12-15 min) 
produced opposing effects on glutamate transmission in CeA neurons from Wistar rats that, 
when averaged together, are not significant (Figure 4C), but when the effects are separated 
into two groups based on an increase or decrease from control, divergent effects emerge. In 
a subset of neurons from Wistar rats, CRF produced a significant increase in sEPSC 
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frequency (144.8 ± 11.7 % of control; n = 6/12; *p<0.05 by one-sample t-test) and in the 
remaining neurons there was a significant decrease in sEPSC frequency (61.8 ± 10.1 % of 
control; n = 6/12; *p<0.05 by one-sample t-test; Figure 4A and 4C). In CeA neurons from 
msP rats, however, the effects of CRF were no longer divergent. CRF produced a significant 
increase in sEPSC frequency in all neurons examined (156.9 ± 11.3 % of control; n = 10/10; 
*p<0.05 by one-sample t-test; Figure 4B and 4C). We observed no neurons that displayed a 
decrease or no change in sEPSC frequency with superfusion of CRF in msP rats, suggesting 
a consistent presynaptic effect of CRF in increasing glutamate release in these animals. In 
addition, CRF produced no significant change in sEPSC amplitude, rise time or decay time 
in either strain.
The divergent effects of CRF on mEPSC frequency in CeA neurons from Wistar rats were 
similar to what was observed with sEPSC frequency, with a subset of CeA neurons 
displaying a significant increase in mEPSC frequency (143.6 ± 14.7 % of control; n = 9/13; 
*p<0.05 by one-sample t-test) and a somewhat smaller subset displaying a decrease in 
mEPSC frequency (76.6 ± 7.5 % of control; n = 4/13; Figure 4D). However, as opposed to 
the uniformly facilitatory effects of CRF on sEPSC frequency in the mSP rats, CRF 
produced divergent effects on mEPSC frequency with a subset of neurons displaying an 
increase (157.5 ± 33.5 % of control; n = 5/11) and the remaining neurons displaying a 
significant decrease (75.5 ± 6.0 % of control; n = 6/11; *p<0.05 by one-sample t-test; 
Figure 4D). CRF produced no significant change in mEPSC amplitude, rise time or decay 
time.
3.4. The effects of CRF receptor-1 blockade on spontaneous CeA glutamatergic 
transmission are unchanged in msP as compared to Wistar rats
In another set of experiments, we assessed the effects of CRF receptor-1 blockade on EPSCs 
in CeA neurons from msP and Wistar rats using the CRF1 antagonist R121919 (1 μM; 12-15 
min). Similar to what was observed with CRF, R121919 produced opposing effects on 
glutamate transmission in CeA neurons from Wistar rats, although of a much smaller overall 
magnitude. When averaged together, these effects are not significant and may simply 
represent a normal distribution with no overall effect (Figure 5C), but when the data are 
separated into two groups, small divergent effects emerge. R121919 produced an increase in 
sEPSC frequency in a subset of neurons from Wistar rats (129.5 ± 14.0 % of control; n = 
7/15) and a significant decrease in the remaining neurons (73.9 ± 4.0 % of control; n = 8/15; 
*p<0.05 by one-sample t-test; Figure 5A and 5C). R121919 also produced divergent effects 
on glutamate transmission in CeA neurons from msP rats. In a subset of neurons R121919 
produced a significant increase in sEPSC frequency (133.9 ± 10.9 % of control; n = 6/13; 
*p<0.05 by one-sample t-test) and in the remaining neurons R121919 produced a significant 
decrease in sEPSC frequency (79.1 ± 6.7 % of control; n =7/13; *p<0.05 by one-sample t-
test; Figure 5B and 5C).
The effects of R121919 on mEPSC frequency in CeA neurons from Wistar and msP rats 
were consistent with what was observed with sEPSC frequency. R121919 produced a small 
but significant increase in mEPSC frequency in a subset of neurons from Wistar rats (112.6 
± 4.0 % of control; n = 7/14; *p<0.05 by one-sample t-test) and produced a significant 
Herman et al. Page 8









decrease in mEPSC frequency in the remaining neurons (66.7 ± 9.2 % of control; n = 7/14; 
*p<0.05 by one-sample t-test; Figure 5D). R121919 also produced divergent effects on 
glutamate transmission in CeA neurons from msP rats, although the proportions were much 
less evenly split than what was observed in neurons from Wistar rats. In a small subset of 
neurons from msP rats R121919 produced an increase in mEPSC frequency (118.8 ± 11.3 % 
of control; n = 2/18) and in the majority of neurons R121919 produced a significant decrease 
in mEPSC frequency (69.0 ± 5.3 % of control; n = 16/18; *p<0.05 by one-sample t-test; 
Figure 5D).
3.5 The ethanol-induced decrease of evoked glutamatergic transmission in the CeA of msP 
and Wistar rats is similar
Here we repeated our previous finding (Kallupi et al., 2014; Roberto et al., 2004a) showing 
that ethanol significantly decreased evoked compound glutamatergic responses in 16 CeA 
neurons (Figure 6A) from Wistar rats. Ethanol (44 mM) significantly (p<0.05 by paired t-
test) decreased the mean amplitude of evoked EPSPs to 84 ± 3% of control over the three 
stimulus intensities with recovery on washout (Figure 6A). This ethanol-induced decrease 
was not associated with a change in the PPF ratios of EPSPs in the CeA of Wistar (control 
PPF 50 and 100 msec: 1.35 ± 0.12 and 1.35 ± 0.12; ethanol: 1.24 ± 0.09 and 1.47 ± 0.15; 
respectively, n=13) or msP rats (control PPF 50 and 100 msec: 1.3 ± 0.16 and 1.26 ± 0.12; 
ethanol: 1.4 ± 0.13 and 1.28 ± 0.15; respectively, n=13) or the I-V relationships (data not 
shown).
3.6 The CRF-induced decrease of evoked glutamatergic transmission in the CeA of Wistar 
rats is lost in msP rats
To determine whether CRF regulates baseline evoked compound glutamatergic 
transmission in the CeA, we applied CRF (100 nM) for a period of 12-15 min during eEPSP 
recordings. A two-way ANOVA revealed a significant difference in the strain responsivity 
to CRF (100 nM) across the intensity strengths tested [F(1,81) = 12.73; p<0.001]. 
Application of CRF significantly (p<0.05) decreased eEPSPs in 12 CeA neurons from 
Wistar rats (Fig. 6B). In contrast, CRF overall did not alter eEPSPs in 17 msP CeA neurons. 
However, the eEPSP amplitude was increased by CRF in 7/17 neurons, while it was 
decreased in 9/17 neurons (one neuron showed no effect). CRF did not alter the PPF ratios 
of EPSPs in the CeA of either Wistar (control PPF 50 and 100 msec: 1.72 ± 0.18 and 1.45 ± 
0.19; CRF: 1.6 ± 0.15 and 1.52 ± 0.11; n=11) or msP rats (control PPF 50 and 100 msec: 
1.36 ± 0.09 and 1.49 ± 0.12; CRF: 1.42 ± 0.13 and 1.58 ± 0.17 ; n=17).
3.7 CRF1 blockade does not affect evoked glutamatergic transmission in CeA of Wistar 
and msP rats
To determine whether CRF1 receptors regulate baseline evoked glutamatergic transmission 
in the CeA, we then tested R121919 (1 μM) for a period of 12-15 min. We found no 
significant effect of the CRF1 antagonist on the evoked glutamate response in CeA neurons 
from either Wistar or msP rats (Figure 6C). R121919 did not alter the PPF ratios of EPSPs 
(Wistar control PPF 50 and 100 msec: 1.50 ± 0.1 and 1.34 ± 0.05; R121919: 1.59 ± 0.08 and 
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1.41 ± 0.08; respectively, n=7; msP control PPF 50 and 100 msec: 1.29 ± 0.07 and 1.28 ± 
0.15; R121919: 1.35 ± 0.12 and 1.41 ± 0.18 respectively, n = 9) in either group.
4. Discussion
The results of this study indicate that msP rats have a dysregulated CeA glutamate system in 
both the basal and stimulated state. Within the CeA, msP rats have an increased level of 
basal spontaneous excitatory glutamatergic activity as compared to Wistar controls, but 
there was no difference in action-potential independent glutamate transmission between the 
two strains. In addition, the effects of ethanol and CRF on spontaneous glutamate 
transmission were altered in CeA neurons from msP rats as compared to Wistar controls, 
suggesting that the response of the CRF system to either acute ethanol or CRF is 
dysfunctional in msP rats. Conversely, the effects of CRF1 blockade were unchanged in msP 
rats as compared to Wistar controls. This suggests that the baseline activity of the CRF1 
receptor is not significantly different in msP rats, although the overall sensitivity of the 
system is altered. Given the significance of the CeA in the behavioral aspects of alcohol 
dependence and the behavioral phenotype of the msP rats, it is likely that the heightened 
glutamatergic state and dysregulated glutamate signaling in the CeA contribute to the 
increased sensitivity to stress, increased anxiety, and increased ethanol consumption 
observed in msP rats.
The majority of the significant differences in glutamatergic transmission that we observed in 
CeA neurons from msP rats occurred in spontaneous, action potential-dependent synaptic 
transmission. In general, there were little to no changes in miniature excitatory postsynaptic 
currents (mEPSCs) between msP and Wistar control rats. There was little to no difference 
between the baseline frequency of action potential-dependent (sEPSC) and action potential-
independent (mEPSC) glutamate transmission in CeA neurons from Wistar rats. This 
suggests that in Wistar rats, the majority of baseline glutamatergic signaling in the CeA is 
driven by vesicular glutamate release and not overall network activity. In msP rats, baseline 
action potential-dependent glutamate transmission (both spontaneous and evoked) was 
significantly higher in the CeA than that observed in neurons from Wistar rats, suggesting 
that the dysregulation associated with the msP phenotype is due mainly to changes in the 
CRF system at the network level. This idea is consistent with the diffuse expression of CRF 
throughout the brain, including at several key sites that form networks with the CeA 
(Gallagher et al., 2008), as well as the heterogeneous expression of CRF1 and CRF2 
receptors at both pre- and postsynaptic sites (Gallagher et al., 2008; Liu et al., 2004; Orozco-
Cabal et al., 2006). The data demonstrating changes in vesicular glutamate release with 
application of ethanol, CRF or the CRF1 antagonist R121919 suggest that these drugs may 
act on distinct sites located at or near the presynaptic terminals. However, the main 
differences observed in spontaneous excitatory postsynaptic currents (sEPSCs) in msP rats 
point to clear network-dependent presynaptic effects of these drugs, possibly within local 
CeA circuitry or from upstream afferents. However, we cannot rule out the possibility of 
postsynaptic effects of either ethanol or the CRF system across the synaptic network. It has 
previously been shown that both CRF and a CRF1 antagonist increase spontaneous 
glutamate release onto lateral CeA neurons, however CRF did not alter selective optical 
stimulation of glutamatergic afferents from the cortex and hippocampus (Silberman and 
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Winder, 2013), suggesting that the effects of CRF are specific to the input pathway or to the 
state of the neuron (spontaneous versus stimulated). The increases in glutamate release 
observed with CRF or a CRF1 antagonist in lateral CeA neurons are consistent with what we 
observed in the medial CeA, suggesting some commonalities between lateral and medial 
CeA. However, the decrease in glutamate release we observed with CRF or a CRF1 
antagonist was not reported in the lateral CeA, suggesting that the medial CeA may possess 
more complex cell populations and/or connectivity.
The effects of ethanol, CRF and the CRF1 antagonist R121919 on glutamatergic 
transmission in the CeA are reported here as divergent and the data are described in two 
separate groups. However, in each case the data are also illustrated with each data point as 
part of a single continuous group to allow for comparisons with the grouped data. In some 
instances the divergent effects are more clear (i.e., with ethanol) while in others the effects 
are smaller in magnitude (R121919), raising the possibility that the effects are not in fact 
divergent, but simply represent an even distribution with a net result of no significant 
change. In all cases, the divergent effects are more pronounced in action potential-dependent 
glutamatergic transmission, which is consistent with a significant role of overall network 
activity in these effects. Given the heterogeneous cell population of the CeA, we 
hypothesize that the divergent effects of ethanol and CRF on spontaneous excitatory 
transmission are the result of differential receptor expression and/or connectivity of distinct 
CeA cell populations. However, as current methods to classify neuronal populations in the 
CeA are lacking, we cannot go into further detail on what specific populations are 
preferentially excited and/or inhibited at this time. Work to clarify the cellular makeup of the 
CeA is ongoing and outside the scope of the present study.
We have previously reported that ethanol decreases evoked EPSP amplitudes in CeA 
neurons of naïve control Sprague Dawley rats, an effect that was not associated with 
significant changes in the PPF ratio, indicating a lack of a significant presynaptic site of 
action for ethanol on evoked glutamatergic transmission (Kallupi et al., 2014; Roberto et al., 
2006; Roberto et al., 2004b). These results were confirmed in the present study in which we 
demonstrated that ethanol-induced decreases of evoked glutamatergic responses in the CeA 
of Wistar rats are equivalent to that of msP rats. CRF, like ethanol, has similar inhibitory 
effects on evoked CeA glutamatergic transmission, without affecting PPF in Wistar rats. 
This observation of the CRF-induced inhibition of locally evoked EPSPs in Wistar rats is in 
agreement with previous work showing that CRF inhibits the BLA to CeA synapses (Liu et 
al., 2004). Notably, in our study, the CRF-induced inhibition of evoked glutamate responses 
is lost in the CeA of msP rats. Finally, application of the CRF1 receptor antagonist did not 
affect evoked glutamatergic responses in either Wistar or msP rats, suggesting the absence 
of tonic CRF1 activity on evoked glutamate release in the CeA. Overall, the differences we 
observe in the effects of ethanol and CRF on spontaneous and evoked glutamatergic 
transmission (bidirectional effects vs. inhibition) are likely due to differential presynaptic 
release mechanisms (different synaptic vesicle pool, release machinery etc..) (Atasoy et al., 
2008).
We recently reported an increase in basal action potential-independent, but not evoked, 
GABA release in the CeA of msP rats as compared to Wistar rats (Herman et al., 2013). We 
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found no difference in the sensitivity of CeA GABAergic synapses to acute ethanol, CRF 
and a CRF1 antagonist compared to Wistar rats. The present study acts as a complement to 
our earlier work examining alterations in the GABA system in msP rats. As a balance 
between excitatory and inhibitory tone is essential to normal network function, it is possible 
that the increased basal GABA release we observed in our previous results is an attempt to 
counter the increased excitatory tone we report in the present study. Notably, the significant 
baseline difference in GABA release observed between msP and Wistar rats was action 
potential-independent pointing to the presynaptic terminal as the critical site for 
dysregulation of the msP GABAergic synapses (Herman et al., 2013). Despite the increased 
baseline GABA release in msP rats, there was no difference in the response of this 
transmission to exogenously applied ethanol, CRF or a CRF1 antagonist (Herman et al., 
2013). Interestingly, our present findings show that the sensitivity of glutamatergic synapses 
to ethanol and CRF is altered in msP rats compared to Wistar rats and this change occurs at 
the network level. Based on our previous and present results, we hypothesize that the innate 
propensity to excessive drinking in the msP rat line may be an attempt to compensate for the 
negative affect-like effects (i.e., anxiety and depression) linked to hyperactivity of the 
extrahypothalamic CRF system that affects both GABAergic and glutamatergic transmission 
in CeA.
Collectively, the results of this study emphasize the critical role of the CRF system in 
normal synaptic functioning of the CeA, and the potential implications for the contribution 
of CeA dysfunction to the behavioral manifestations of stress, anxiety and alcohol 
dependence, although these are complex disorders that almost certainly involve dysfunction 
in a number of brain areas and systems beyond the CeA. The commonalities of the msP rats 
with ethanol dependent rats on a cellular (both glutamatergic and GABAergic systems) and 
behavioral level suggest that upregulation of the CRF system plays a dominant role in the 
CeA abnormalities associated with alcoholism (Sommer et al., 2008). Given that 
acamprosate (Campral), which may act by antagonizing glutamatergic receptors, is one of 
the few effective therapeutic options for alcoholism (De Witte et al., 2005; Koob et al., 
2002; Mann et al., 2008), the dysregulation of the glutamate system observed in msP rats 
may provide some insight into the role of dysregulated CeA glutamate in alcohol 
dependence. Thus, the CRF system may be an important target, either for the identification 
of individuals with an inherent genetic vulnerability to alcohol dependence or in the 
development of therapeutics to treat alcohol dependence in vulnerable individuals.
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CeA glutamate release is elevated in msP rats compared to Wistar rats
EtOH produces divergent effects on glutamate release in msP and Wistar rats
The increase in CeA glutamate release with EtOH is less in msP than in Wistar rats
CRF produces divergent effects on glutamate release in Wistar rats
In CeA neurons of msP rats CRF only increases glutamate release
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Baseline spontaneous glutamate transmission is elevated in msP rats as compared to Wistar 
rats. A) Representative sEPSCs in CeA neurons from a Wistar rat (top trace) and an msP rat 
(bottom trace). B) Representative mEPSCs in CeA neurons from a Wistar rat (top trace) and 
an msP rat (bottom trace). C) Summary (mean ± SEM) of baseline sEPSC frequency in CeA 
neurons from Wistar (n = 26) and msP (n = 19) rats (*p<0.05 by unpaired t-test). D) 
Summary of baseline mEPSC frequency in CeA neurons from Wistar (n = 18) and msP (n = 
17) rats.
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Baseline evoked EPSP amplitudes are elevated in CeA neurons of msP rats compared to 
Wistar rats. A) Top panel: Representative evoked glutamatergic-EPSPs in CeA neurons 
from Wistar and msP rats. Bottom Panel: The input-output curves of mean baseline eEPSPs 
are enhanced in CeA neurons from msP (n = 38) compared to Wistar rats (n = 28). B) Top 
Panel: Representative recordings of evoked 50 and 100 msec PPF of eEPSPs in CeA 
neurons from msP and Wistar rats. Bottom Panel: Histograms (mean ± SEM) plotting the 
baseline PPF ratio of eEPSPs in CeA neurons from msP and Wistar rats. In the msP (n = 38) 
baseline PPF ratios are significantly (*p< 0.05) lower than Wistar (n = 26) neurons.
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The divergent effects of ethanol on CeA glutamatergic transmission are altered in msP rats 
as compared to Wistar rats. A) Representative sEPSCs in CeA neurons from a Wistar rat 
showing an increase (left) and decrease (right) in sEPSC frequency following ethanol (EtOH 
44 mM) superfusion. B) Representative sEPSCs in a CeA neuron from a msP rat showing a 
small increase in sEPSC frequency (left) and a decrease in sEPSC frequency following 
ethanol (EtOH 44mM) superfusion. C) Left panel: Scatterplot displaying the unbinned 
individual changes in sEPSC frequency following ethanol application in each cell. Center 
panel: Scatterplot displaying the individual changes in sEPSC frequency in each cell 
grouped by net change from control levels. Right panel: Summary (mean ± SEM) of the 
change in sEPSC frequency (% of control) following ethanol superfusion in CeA neurons 
from Wistar (n = 17) and msP (n = 17) rats (*p<0.05 by one sample t-test; #p<0.05 by one-
way ANOVA with Bonferroni post hoc comparison). D) Left panel: Scatterplot displaying 
the unbinned individual changes in mEPSC frequency following ethanol application in each 
cell. Center panel: Scatterplot displaying the individual changes in mEPSC frequency in 
each cell grouped by net change from control levels. Right panel: Summary (mean ± SEM) 
of the change in mEPSC frequency (% of control) following ethanol superfusion in CeA 
neurons from Wistar (n = 18) and msP (n = 13) rats.
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The divergent effects of CRF on CeA glutamatergic transmission are lost in msP rats as 
compared to Wistar rats. A) Representative sEPSCs in CeA neurons from a Wistar rat 
showing an increase (left) and decrease (right) in sEPSC frequency following CRF (100 nM) 
superfusion. B) Representative sEPSCs in a CeA neuron from an msP rat showing an 
increase in sEPSC frequency following CRF superfusion. C) Left panel: Scatterplot 
displaying the unbinned individual changes in sEPSC frequency following CRF application 
in each cell. Center panel: Scatterplot displaying the individual changes in sEPSC 
frequency in each cell grouped by net change from control levels. Right panel: Summary 
(mean ± SEM) of the change in sEPSC frequency (% of control) following CRF superfusion 
in CeA neurons from Wistar (n = 12) and msP (n = 10) rats (*p<0.05 by one sample t-test). 
D) Left panel: Scatterplot displaying the unbinned individual changes in mEPSC frequency 
following CRF application in each cell. Center panel: Scatterplot displaying the individual 
changes in mEPSC frequency in each cell grouped by net change from control levels. Right 
panel: Summary (mean ± SEM) of the change in mEPSC frequency (% of control) 
following CRF superfusion in CeA neurons from Wistar (n = 13) and msP (n = 11) rats.
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The divergent effects of CRF1 receptor blockade on CeA glutamatergic transmission are 
retained in msP rats as compared to Wistar rats. A) Representative sEPSCs in CeA neurons 
from a Wistar rat showing an increase (left) and decrease (right) in sEPSC frequency 
following R121919 (1 μM) superfusion. B) Representative sEPSCs in CeA neurons from 
msP rats showing an increase (left) and a decrease in sEPSC frequency (right) following 
R121919 (1 μM) superfusion. C) Left panel: Scatterplot displaying the unbinned individual 
changes in sEPSC frequency following R121919 application in each cell. Center panel: 
Scatterplot displaying the individual changes in sEPSC frequency in each cell grouped by 
net change from control levels. Right panel: Summary (mean ± SEM) of the change in 
sEPSC frequency (% of control) following R121919 superfusion in CeA neurons from 
Wistar (n = 15) and msP (n = 13) rats (*p<0.05 by one sample t-test). D) Left panel: 
Scatterplot displaying the unbinned individual changes in mEPSC frequency following 
R121919 application in each cell. Center panel: Scatterplot displaying the individual 
changes in mEPSC frequency in each cell grouped by net change from control levels. Right 
panel: Summary (mean ± SEM) of the change in mEPSC frequency (% of control) 
following R121919 superfusion in CeA neurons from Wistar (n = 14) and msP (n = 18) rats.
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Effects of ethanol, CRF and R121919 on evoked EPSP amplitude in CeA neurons of Wistar 
and msP rats. A) Ethanol significantly and reversibly decreases EPSP amplitude. Top: 
Representative eEPSPs in CeA neurons of Wistar and msP rats during baseline, ethanol (44 
mM) and washout. Bottom: Ethanol significantly (*p<0.05 by paired t-test) decreases the 
mean amplitudes of eEPSP over the middle three stimulus strength intensities tested in both 
Wistar and msP rats. B) CRF significantly (*p<0.05) decreases eEPSP amplitudes in the 
CeA of Wistar rats, but had no effect in msP rats (#p<0.05 as compared to Wistar by two-
way ANOVA). Top: Representative CeA eEPSP recordings from Wistar and msP rats 
during baseline, CRF (100 nM), and washout. Bottom: CRF decreases the mean amplitude 
of eEPSPs in CeA neurons of Wistar, but not msP, rats. C) The CRF1 antagonist, R121919, 
does not alter eEPSP amplitudes in either strain. Top: Representative eEPSPs in CeA 
neurons of Wistar and msP rats during baseline, R121919 (1μM) and washout. Bottom: 
R121919 does not affect the mean amplitudes of eEPSPs over the middle three stimulus 
strength intensities in either Wistar or msP rats.
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